CB Insights
Technology Market Intelligence
Technology Market Intelligence
Public list: Pharma Startups (6570) Cancer Therapeutics (1180)
Unibioscreen is a specialist oncology discovery & development company, with focus on 'first in class' drugs, mainly of natural origin. Unibioscreen has successfully developed 2 drug candidates from discovery to clinical development in cancer patients...Show all
Company (Alive / Active)
Avenue Joseph Wybran 40
1070
Belgium
| Total Funding | Date of Last Funding | |
|---|---|---|
| Unibioscreen | $0M | Oct 10, 2019 |
| Humanetics Corporation | $0.6M | Oct 10, 2017 |
| Activate Immunotherapy | $0M | Aug 15, 2016 |
| See all 23 competitors | ||
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| 2″ oxo-voruscharin and derivatives thereof | Dec 13, 2007 | Jul 19, 2011 | Patent |
| Azonafide derivatives, methods for their production and pharmaceutical compositions therefrom | Nov 09, 2006 | Jun 22, 2010 | Patent |
